D. Chernoff

D. Chernoff, M. Holodniy, C. Pachl, 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Outcomeof Parameters Affecting Assay Plasma: Immunodeficiency Virus Type 1 RNA in Determinations of Levels of Human

T. Quinn, L. Mofenson, M. Robb, 2013 .

Evaluation of the impact of age and adiposity on a multi-biomarker disease activity score before and after adjustment

E. Sasso, J. Long, J. Baker, 2020, Clinical Rheumatology.

Upper and middle lobe bronchoalveolar lavage to diagnose Pneumocystis carinii pneumonia.

J. Golden, R. Yung, D. Chernoff, 1993, The American review of respiratory disease.

Variance of plasma human immunodeficiency virus type 1 RNA levels measured by branched DNA within and between days.

M. Schambelan, M. Feinberg, D. Chernoff, 1997, The Journal of infectious diseases.

Safety and immunogenicity of Env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59. NIAID AIDS Vaccine Evaluation Group.

D. Stablein, B. Graham, L. Corey, 1996, AIDS research and human retroviruses.

Identification of the minor guanylated tRNA of rabbit reticulocytes.

D. Chernoff, W. Farkas, 1976, Nucleic acids research.

Hepatitis C virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs.

S. O’Brien, C. Winkler, E. Daar, 2001, The Journal of infectious diseases.

Oral histoplasmosis in HIV-infected patients. A report of two cases.

D. Chernoff, S. Silverman, C. Migliorati, 1995, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

Intravenous or inhaled pentamidine for treating Pneumocystis carinii pneumonia in AIDS. A randomized trial.

J. Golden, D. Chernoff, D. Feigal, 1990, Annals of internal medicine.

PREVENTION OF PNEUMOCYSTIS CARINII PNEUMONIA BY INHALED PENTAMIDINE

J. Golden, D. Chernoff, D. Feigal, 1989, The Lancet.

Elevated serum concentrations of IgE antibodies to environmental antigens in HIV-seropositive male homosexuals.

E. Goetzl, D. Chernoff, H. Hollander, 1990, The Journal of allergy and clinical immunology.

Effect of prebiotics on the fecal microbiota of elderly volunteers after dietary supplementation of Bacillus coagulans GBI-30, 6086.

G. Gibson, D. Chernoff, S. Farmer, 2014, Anaerobe.

Relation Between HIV‐1 and Hepatitis C Viral Load in Patients With Hemophilia

C. Winkler, E. Daar, D. Chernoff, 2001, Journal of acquired immune deficiency syndromes.

Increased transmission of vertical hepatitis C virus (HCV) infection to human immunodeficiency virus (HIV)-infected infants of HIV- and HCV-coinfected women.

W. Borkowsky, D. Chernoff, H. Pollack, 1998, The Journal of infectious diseases.

The Effect of Plasma Human Immunodeficiency Virus RNA and CD4+ T Lymphocytes on Growth Measurements of Hemophilic Boys and Adolescents

E. Daar, D. Chernoff, M. Hilgartner, 2001, Pediatrics.

Reduced dose or aerosolized pentamidine treatment for pneumocystis carinii pneumonia pcp 3 6 month follow up

J. Golden, D. Chernoff, D. Feigal, 1989 .

The Significance of HIV Viral Load Assay Precision: A Review of the Package Insert Specifications of Two Commercial Kits

D. Chernoff, 2002, Journal of the International Association of Physicians in AIDS Care.

Relation between HIV-1 and hepatitis C viral load in patients with hemophilia.

C. Winkler, E. Daar, D. Chernoff, 2001 .

Effects of plasma HIV RNA, CD4+ T lymphocytes, and the chemokine receptors CCR5 and CCR2b on HIV disease progression in hemophiliacs. Hemophilia Growth and Development Study.

S. O’Brien, C. Winkler, E. Daar, 1999, Journal of acquired immune deficiency syndromes.

Quantification of Human Immunodeficiency Virus Type 1 RNA Levels in Plasma by Using Small-Volume-Format Branched-DNA Assays

Yuqi Zhao, D. Chernoff, R. Yogev, 1998, Journal of Clinical Microbiology.

Quantification of cytomegalovirus DNA in peripheral blood leukocytes by a branched-DNA signal amplification assay

D. Chernoff, J. Kolberg, J. Lalezari, 1997, Journal of clinical microbiology.

Does HIV cause salivary gland disease?

J. Levy, D. Chernoff, J. Greenspan, 1989, AIDS.

Longitudinal Analysis of Quantitative Virologic Measures in Human Immunodeficiency Virus-Infected Subjects with ⩾400 CD4 Lymphocytes: Implications for Applying Measurements to Individual Patients

Robert W. Coombs, Lisa M. Demeter, Lawrence Corey, 1997 .

Cardiac manifestations of human immunodeficiency virus infection: a two-dimensional echocardiographic study.

D. Chernoff, N. Schiller, H. Hollander, 1989, Journal of the American College of Cardiology.

Bacillus coagulans GBI-30, 6086 Modulates Faecalibacterium prausnitzii in Older Men and Women.

G. Gibson, D. Chernoff, H. Cash, 2015, The Journal of nutrition.

Clinical, immunologic, and virologic observations related to human immunodeficiency virus (HIV) type 1 infection in a volunteer in an HIV-1 vaccine clinical trial.

J. Kahn, K. Steimer, T. Elbeik, 1995, The Journal of infectious diseases.

Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection.

M. Schambelan, C. Grunfeld, D. Chernoff, 2000 .

Hyperlipidemia and Insulin Resistance Are Induced by Protease Inhibitors Independent of Changes in Body Composition in Patients With HIV Infection

M. Schambelan, C. Grunfeld, D. Chernoff, 2000, Journal of acquired immune deficiency syndromes.

Impact of Rheumatoid Arthritis Disease Activity Test on Clinical Practice

V. Strand, D. Chernoff, R. Shimkhada, 2013, PloS one.

The Fourth Bioelectronic Medicine Summit “Technology Targeting Molecular Mechanisms”: current progress, challenges, and charting the future

Theodoros P. Zanos, Eric H. Chang, M. Berggren, 2021, Bioelectronic medicine.

Two double-blinded, randomized, comparative trials of 4 human immunodeficiency virus type 1 (HIV-1) envelope vaccines in HIV-1-infected individuals across a spectrum of disease severity: AIDS Clinical Trials Groups 209 and 214.

B. Walker, R. Schooley, M. Hirsch, 2000, The Journal of infectious diseases.

Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity

G. Cavet, M. Weinblatt, N. Shadick, 2012, Arthritis care & research.

Safety and efficacy of ADS-5102 (amantadine) extended release capsules to improve walking in multiple sclerosis: A randomized, placebo-controlled, phase 2 trial

Jeffrey A. Cohen, R. Patni, D. Chernoff, 2019, Multiple sclerosis.

Investigation of a multi-biomarker disease activity score in rheumatoid arthritis by comparison with magnetic resonance imaging, computed tomography, ultrasonography, and radiography parameters of inflammation and damage

E. Sasso, C. Brahe, D. Chernoff, 2017, Scandinavian journal of rheumatology.

Association of a multibiomarker disease activity score at multiple time-points with radiographic progression in rheumatoid arthritis: results from the SWEFOT trial

E. Sasso, S. Saevarsdottir, D. Chernoff, 2016, RMD Open.

Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial

E. Sasso, S. Saevarsdottir, D. Chernoff, 2014, Annals of the rheumatic diseases.

Racial and Ethnic Differences in Outcome in Zidovudine-Treated Patients With Advanced HIV Disease

Douglas D. Richman, Harold A. Kessler, Richard D. Moore, 1991 .

Multi-biomarker disease activity score as a predictor of disease relapse in patients with rheumatoid arthritis stopping TNF inhibitor treatment

W. Lems, M. A. van de Laar, D. van Schaardenburg, 2018, PloS one.

Long latency event‐related potentials in patients infected with human immunodeficiency virus

M. Aminoff, D. Chernoff, H. Hollander, 1990, Annals of neurology.

Variations and Practice in the Care of Patients With Rheumatoid Arthritis: Quality and Cost of Care

D. Chernoff, J. Luck, J. Peabody, 2014, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

FRI0061 Multi-biomarker disease activity (MBDA) score and the 12 individual biomarkers in early rheumatoid arthritis patients relate differentially to clinical response and radiographic progression: results from the swefot trial

E. Sasso, S. Saevarsdottir, D. Chernoff, 2013 .

A10.22 Response to MTX Plus Prednisone in Camera II Using a Multi-Biomarker Disease Activity (Vectra™DA) TEST and DAS28-ESR

G. Cavet, D. Chernoff, J. Bijlsma, 2013 .

Modular Analysis of Peripheral Blood Gene Expression in Rheumatoid Arthritis Captures Reproducible Gene Expression Changes in Tumor Necrosis Factor Responders

Michaela Oswald, Peter K Gregersen, Annette Lee, 2015, Arthritis & rheumatology.

In vivo emergence of drug-resistant mutations at less than 50 HIV-1 RNA copies/mL that are maintained at viral rebound in longitudinal plasma samples from human immunodeficiency virus type-1-infected patients on highly active antiretroviral therapy.

T. Elbeik, D. Chernoff, V. Ng, 2001, Journal of human virology.

Proinflammatory cytokine and human immunodeficiency virus RNA levels during early Mycobacterium avium complex bacteremia in advanced AIDS.

M. Lederman, D. Haas, L. Clough, 1998, The Journal of infectious diseases.

Triple Combination Nitazoxanide, Ribavirin, and Hydroxychloroquine results in the multiplicative reduction of in vitro SARS-CoV-2 viral replication

Gabriela Ramirez, R. Perera, D. Chernoff, 2020, bioRxiv.

Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response.

N. Cox, T. Heeren, D. Chernoff, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Longitudinal analysis of quantitative virologic measures in human immunodeficiency virus-infected subjects with > or = 400 CD4 lymphocytes: implications for applying measurements to individual patients. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.

M. McElrath, L. Corey, D. Chernoff, 1997, The Journal of infectious diseases.

Determination of the minimally important difference (MID) in multi-biomarker disease activity (MBDA) test scores: impact of diurnal and daily biomarker variation patterns on MBDA scores

Xingbin Wang, D. Chernoff, J. Curtis, 2018, Clinical Rheumatology.